Sano Women's Health
- Biotech or pharma, animal health
Sano’s is a clinical stage drug discovery and development company focused in women’s health, anti-infectives and oncology. Sano’s lead asset, Occidiofungin is dosing patients for Phase 1 MAD clinical study which should be completed by early June. Sano completed a Phase 1 SAD clinical trial in May 2024.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}